- New
- Biomarker
- robust evidence
- 4 min · 4 sources
- Published Aug 8, 2026
Glucose Management Indicator (GMI) and Time in Range
CGM report numbers that show average glucose and time in range
Use them to spot hidden lows and spikes that a single lab average can miss.
Also known as GMI · glucose management indicator · TIR · time in range · CGM metrics · ambulatory glucose profile · AGP report · estimated A1C · eA1C
Glucose Management Indicator (GMI) and Time in Range in brief
- GMI converts average CGM glucose into an estimated A1C, not a laboratory blood test.2
- Time in Range counts the proportion of the day glucose stays inside the chosen target range.
- GMI and laboratory A1C can disagree when red blood cell turnover is unusual.
What Glucose Management Indicator (GMI) and Time in Range means
The same A1C can hide two different days
A continuous glucose monitor report can show two headline numbers that look redundant: GMI and Time in Range. They are not duplicates. One turns your sensor average into an A1C shaped number. The other counts minutes.
Here is the surprise: two people can have a similar GMI, yet one spends most of the day between 70 and 180 mg/dL while the other swings from low to high and back again. Their averages can match, but their lived days are different. That is why modern CGM reports show both numbers instead of replacing one with the other.
What GMI actually calculates
Glucose Management Indicator, or GMI, is calculated from the average glucose recorded by a continuous glucose monitor. In the United States, the formula is: GMI (%) = 3.31 + 0.02392 x mean glucose in mg/dL. If your CGM average is about 154 mg/dL, the GMI is about 7.0 percent. If your average is 180 mg/dL, the GMI is about 7.6 percent.
GMI was created because the older phrase, estimated A1C, caused a specific problem: people expected it to equal the lab A1C drawn from blood. The U.S. Food and Drug Administration objected to the older name because it could imply that a sensor calculation was the same thing as a laboratory A1C. The new name keeps the useful estimate while making the difference clearer.
A lab A1C measures how much glucose has attached to hemoglobin, the oxygen carrying protein inside red blood cells. GMI does not measure red blood cells. It is math from sensor glucose. That means GMI may be higher or lower than lab A1C when red blood cells live for a shorter or longer time, after recent glucose changes, during pregnancy, with kidney disease, anemia, blood loss, transfusion, or some hemoglobin variants.
What Time in Range counts
Time in Range, or TIR, is the percentage of CGM readings between a chosen lower and upper glucose limit. For most nonpregnant adults with type 1 or type 2 diabetes, the standard target range is 70 to 180 mg/dL. A common goal is more than 70 percent of the day in range, which is about 17 hours per day. The same consensus targets also aim for less than 4 percent below 70 mg/dL, less than 1 percent below 54 mg/dL, less than 25 percent above 180 mg/dL, and less than 5 percent above 250 mg/dL.
Pregnancy uses tighter CGM ranges. For type 1 diabetes in pregnancy, the consensus target range is 63 to 140 mg/dL, with different goals because fetal exposure to glucose matters and low glucose risk must also be watched carefully.
The decision to make today
If you are looking at a CGM report, do not react to GMI first. First check Time Below Range. If lows are above target, bring that pattern to your clinician before trying to lower GMI. A lower average is not progress if it is being bought with unsafe lows. Once lows are controlled, Time in Range and GMI become more useful for judging meals, medication timing, activity, sleep, and whether a change is helping.
How it works
GMI is built from mean interstitial glucose, which is glucose measured in fluid between cells rather than directly inside a vein. CGM devices sample this fluid repeatedly, then software averages the readings. Time in Range uses the same readings but does not average them. It sorts each reading into below range, in range, or above range, then reports the percentage of recorded time in each bucket.
The term in the wild
-
You open Dexcom Clarity and see average glucose 154 mg/dL, GMI 7.0 percent, and Time in Range 72 percent from 14 days of data.
The GMI says your sensor average lines up with an A1C shaped value near 7 percent. The Time in Range says roughly 17 hours per day were between 70 and 180 mg/dL.
This pattern is close to the common consensus target for many nonpregnant adults, but the next safety check is whether time below 70 mg/dL stayed under 4 percent.
-
Your lab A1C is 6.8 percent, but LibreView shows GMI 7.4 percent and only 55 percent Time in Range.
The lab and sensor are answering different questions. The lab A1C reflects glucose attached to red blood cells, while GMI comes from recent sensor average glucose.
The mismatch is not automatically a sensor failure. It is a reason to review CGM wear time, recent glucose changes, anemia, kidney disease, pregnancy status, or other factors with a clinician.
-
A supplement forum claims berberine improved someone’s Time in Range from 48 percent to 65 percent in two weeks.
Time in Range can show a real pattern change, but the claim needs context: medication changes, diet, weight change, illness, sensor wear, and low glucose time can all move the number.
For glucose active supplements such as berberine, the safety issue is not just higher Time in Range. It is whether time below 70 mg/dL increased, especially if the person also uses insulin or a sulfonylurea.
-
A pregnancy CGM report shows 70 to 180 mg/dL targets, but the endocrinology team talks about 63 to 140 mg/dL.
Pregnancy uses different CGM targets than the common adult diabetes range. The tighter range changes what counts as in range.
Using the wrong range can make a report look better than it is for pregnancy specific care.
What people get wrong
-
Myth
GMI is just your A1C before the lab confirms it.
Why people believe it The older label, estimated A1C or eA1C, made the number sound interchangeable with a lab A1C. The 2018 Diabetes Care paper explains that FDA concern about this wording helped drive the name change to GMI.
Reality
GMI is a sensor based calculation. Lab A1C is a blood measurement involving red blood cells. They often move together, but they are not the same test.
-
Myth
A good GMI means glucose control is safe.
Why people believe it A1C centered care trained many people to treat a single average as the main scoreboard, while CGM reports separate average glucose from low glucose exposure.
Reality
A good average can hide too many lows. Time Below Range shows whether the average is being pulled down by glucose values under 70 mg/dL or under 54 mg/dL.
-
Myth
Time in Range always means 70 to 180 mg/dL.
Why people believe it CGM apps and articles often display the adult default range first, so readers may not realize the range is adjustable and population specific.
Reality
That is the common range for many nonpregnant adults with diabetes, but pregnancy and some high risk situations use different targets.
Putting Glucose Management Indicator (GMI) and Time in Range to work
A specific failure mode is comparing two CGM reports when one has poor sensor coverage. Consensus reporting uses at least 14 days with about 70 percent active CGM data for a reliable snapshot. If a report has large gaps, treat the GMI and Time in Range as clues, not a verdict.
Common questions
How many days of CGM data do I need before GMI and Time in Range are meaningful?
Which number should I bring up first at a diabetes visit?
Can GMI be used to diagnose diabetes?
Why did my GMI improve before my lab A1C changed?
Do supplements that affect glucose show up in Time in Range?
Sources
Sources
- 1. Clinical Targets for Continuous Glucose Monitoring Data Interpretation: Recommendations From the International Consensus on Time in Range (2019)
- 2. Glucose Management Indicator (GMI): A New Term for Estimating A1C From Continuous Glucose Monitoring (2018)
- 3. Glucose Management Indicator (GMI)
- 4. Clinical Targets for Continuous Glucose Monitoring Data (2020)